<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Hoyle, Brian</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Preiss, David</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Should We Worry about Raised Triglycerides?</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2013</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2013-11-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">29-29</style></pages><abstract><style  face="normal" font="default" size="100%">This article discusses elevated triglycerides (TGs) and whether they pose a concern. The question becomes relevant when treating, for example, a type 2 diabetic patient at high risk of cardiovascular disease (CVD) with elevated TGs and low high-density lipoprotein cholesterol. Lifestyle modifications including exercise, weight loss, diet, altered consumption of alcohol, and judicious and relevant medication use are sound. But the focus of treatment (CVD risk and/or pancreatitis risk and/or microvascular risk) is more problematic and contentious.</style></abstract><number><style face="normal" font="default" size="100%">17</style></number><volume><style face="normal" font="default" size="100%">13</style></volume></record></records></xml>